Jubilant Pharmova Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA1,4141,168
EBIT1,044786
Earning Per Share3626
Expenses4,7024,974
Net Profit824423
Net Profit Margin97
Operating Profit Margin2319
Profit Before Tax860640
Dividends Per Share55
Operation Revenue6,1166,141

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Jubilant Pharmova is 1,168 as of 2/26/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20132013201320132023
Operating Activities970970970970661
Investing Activities-500-500-500-500-544
Financing Activities-450-450-450-450-157
Others00000
Net Cash Flow20202020-40

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Jubilant Pharmova is 661 as of 2/26/2024